Bml Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 9,395,934 shares of ACRS stock, worth $11.2 Million. This represents 7.8% of its overall portfolio holdings.
Number of Shares
9,395,934
Previous 653,107
1338.65%
Holding current value
$11.2 Million
Previous $686 Million
1598.98%
% of portfolio
7.8%
Previous 0.52%
Shares
2 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Black Rock Inc. New York, NY5.2MShares$6.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$5.87 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$3.91 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.9 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3MShares$3.57 Million0.56% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $79.3M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...